Daclizumab

Category: Immunosuppressive



Daclizumab Overview

Daclizumab (trade name Zinbryta, by Biogen) is a therapeutic humanized monoclonal antibody used for the treatment of adults with relapsing forms of multiple sclerosis (MS). Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T-cells. It was formerly marketed under the trade name Zenapax to prevent acute rejection in people with kidney transplants along with cyclosporine and corticosteroids but marketing of the drug for that purpose was discontinued in 2009 due to la...

Read more Daclizumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Daclizumab

Recent Daclizumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Daclizumab
  • Injection: 150mg/ml, 5mg/ml
  • Vial: 25mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Daclizumab or a similar ingredient: (2 results)